We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
41 hedge funds and large institutions have $45.8M invested in scPharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
180% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 5
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
8% more funds holding
Funds holding: 38 → 41 (+3)
1.23% less ownership
Funds ownership: 44.88% → 43.65% (-1.2%)
56% less capital invested
Capital invested by funds: $103M → $45.8M (-$57.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
41
Holders Change
+3
Holders Change %
+7.89%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
14
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AIC
AWM Investment Company
New York
|
+$1.98M |
| 2 |
BlackRock
New York
|
+$613K |
| 3 |
Morgan Stanley
New York
|
+$542K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$306K |
| 5 |
CG
Colony Group
Boston,
Massachusetts
|
+$238K |
